Answers are grounded in this paper and cite their sources.
Public omics repositories and multi‐omics technologies have substantially expanded the molecular characterization of chronic human diseases by enabling large‐scale analyses across diverse biological and clinical contexts. However, in neurological disorders, translating omics‐derived associations into mechanistic insight and clinical relevance remains challenging due to the dynamic and multiscale nature of brain function. Gene set–based analytical approaches effectively identify enriched molecular patterns, but are limited in capturing temporal dynamics, network‐level interactions, and physiological state dependence that define neural systems. This conceptual methodological review synthesizes foundational infrastructure papers, methodological evaluations, and translational neuroscience literature to critically examine the application of public omics resources in human neurophysiology, focusing on the interpretive gap between molecular‐level associations and functional brain processes. We examine major public omics infrastructures, widely used gene set analysis frameworks, the principal strategies for multi‐omics integration, and the challenge of batch effects in public data reuse, highlighting both their analytical strengths and structural limitations. Core neurophysiological principles, including synaptic transmission, network dynamics, plasticity, and homeostatic regulation, are discussed to clarify why direct inference from static molecular profiles to brain function is inherently constrained. Clinical illustrations from epilepsy, attention‐deficit/hyperactivity disorder, and migraine demonstrate how chronic neurological disorders emerge from context‐dependent neural dynamics that are not readily reducible to gene set–level summaries. Finally, we outline future directions for integrating artificial intelligence with public omics resources, emphasizing physiology‐informed modeling, explainable AI, and ethical considerations to support more interpretable and translational precision health strategies in chronic neurological disease.
No takes yet. Share an insight, caveat, or question.
Rukiye Ölçüoğlu (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: